These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24369747)

  • 1. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
    Kilicarslan M; Koerber M; Bodmeier R
    Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
    Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
    Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo investigation of drug-eluting implants for the treatment of periodontal disease.
    Lee FY; Chen DW; Hu CC; Hsieh YT; Liu SJ; Chan EC
    AAPS PharmSciTech; 2011 Dec; 12(4):1110-5. PubMed ID: 21879391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets.
    de Sousa FO; Blanco-Méndez J; Pérez-Estévez A; Seoane-Prado R; Luzardo-Álvarez A
    J Biomater Appl; 2012 Aug; 27(2):187-200. PubMed ID: 21586598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
    Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Kaseem A; Nutan MT; Hussain MD
    J Pharm Sci; 2012 Oct; 101(10):3753-62. PubMed ID: 22753324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole and Pentoxifylline films for the local treatment of chronic periodontal pockets: preparation, in vitro evaluation and clinical assessment.
    Labib GS; Aldawsari HM; Badr-Eldin SM
    Expert Opin Drug Deliv; 2014 Jun; 11(6):855-65. PubMed ID: 24641528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
    Cho KY; Lee S; Park JK
    Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment.
    Do MP; Neut C; Metz H; Delcourt E; Siepmann J; Mäder K; Siepmann F
    Eur J Pharm Biopharm; 2015 Aug; 94():273-83. PubMed ID: 26047797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
    Ahmed TA; Ibrahim HM; Samy AM; Kaseem A; Nutan MT; Hussain MD
    AAPS PharmSciTech; 2014 Jun; 15(3):772-80. PubMed ID: 24648158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical key properties of antibiotic-free, PLGA/HPMC-based in-situ forming implants for local periodontitis treatment.
    Agossa K; Lizambard M; Rongthong T; Delcourt-Debruyne E; Siepmann J; Siepmann F
    Int J Pharm; 2017 Apr; 521(1-2):282-293. PubMed ID: 28223246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
    Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
    Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.
    Gad HA; El-Nabarawi MA; Abd El-Hady SS
    AAPS PharmSciTech; 2008; 9(3):878-84. PubMed ID: 18654864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on development of controlled delivery of combination drug(s) to periodontal pocket.
    Tiwari G; Tiwari R; Rai AK
    Indian J Dent Res; 2010; 21(1):72-83. PubMed ID: 20427912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive in vivo characterization of microclimate pH inside in situ forming PLGA implants using multispectral fluorescence imaging.
    Schädlich A; Kempe S; Mäder K
    J Control Release; 2014 Apr; 179():52-62. PubMed ID: 24503251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: approaches to develop PLGA based in situ gelling system with low initial burst.
    Ahmed T
    Pak J Pharm Sci; 2015 Mar; 28(2):657-65. PubMed ID: 25730797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole-loaded bioabsorbable films as local antibacterial treatment of infected periodontal pockets.
    Shifrovitch Y; Binderman I; Bahar H; Berdicevsky I; Zilberman M
    J Periodontol; 2009 Feb; 80(2):330-7. PubMed ID: 19186975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology.
    Greenstein G; Tonetti M
    J Periodontol; 2000 Jan; 71(1):125-40. PubMed ID: 10695948
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ethylcellulose and propylene glycol on the controlled-release performance of glyceryl monooleate-mertronidazole periodontal gel.
    Sallam AS; Hamudi FF; Khalil EA
    Pharm Dev Technol; 2015 Mar; 20(2):159-68. PubMed ID: 24262092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.